|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of Smad2 and Smad4 in cervical cancer:absent nuclear Smad4 expression cor- relates with poor survival 显示文摘 | KENTER GG SPIJKER HS ULJEE S | 2008 | Mod Pathol2008，21，7： | 1 |
| 2 | Phase I immunother- apeutic trial with long peptides spanning the E6 and E7 sequences of high - risk human papillomavirus 16 in end - stage cervical cancer patients shows low toxicity and robust immunogenicity 显示文摘 | Kenter GG Welters MJ Valentijin AR | 2008 | Clin Cancer Res2008，14，1： | 1 |
| 3 | Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer显示文摘 | DE JONG A VAN DER HULST JM KENTER GG | 2005 | Int J Cancer2005，114，2： | 1 |
| 4 | Nerve sparing radical hysterectomy: Local recurrence rate, feasibility, and safety in cervical cancer patients stage Ⅰ A to Ⅱ A 显示文摘 | Van den Tillaart SA Kenter GG Peters AA | 2009 | Int J Gyneeol Cancer2009，19，1： | 1 |
| 5 | The number of pel- vic lymph nodes in the quality control and prognosis of radical hyster- ectomy for the treatment of cervical cancer 显示文摘 | Pieterse QD Kenter GG Gaarenstroom KN | 2007 | Eur J Surg Oncol2007，33，2： | 1 |
| 6 | The number of pelvic lymph nodes in the quality control and pronosis of radical hysterectomy for the treatment of cervical cancer显示文摘 | Pieterse QD Kenter GG Gasrenstroom KN | | 0，，02： | 1 |
| 7 | Vaccination with HPV16 peptides of patients with advanced cervical carcinoma:clinical evaluation of a phase Ⅰ-Ⅱ trial显示文摘 | van Driel WJ Ressing ME Kenter GG | 1999 | Eur J Cancer1999，35，6： | 1 |
| 8 | High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients显示文摘 | Jordanova ES Kenter GG | 2007 | Clin Cancer Res2007，13，1： | 1 |
| 9 | Phase Ⅰ immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity显示文摘 | Kenter GG Welters M J Valentijn AR | 2008 | Clin Cancer Res2008，14，1： | 1 |
| 10 | The long learning curve of gynecological cancer surgery: an argument for centralization 显示文摘 | Trimbos JB Hellebrekers BW Kenter GG | 2000 | BJOG2000，107，1： | 1 |
| 11 | Induction of tumorspecific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine显示文摘 | Welters M J Kenter GG Piersma SJ | 2008 | Clin Cancer Res2008，14，1： | 1 |
| 12 | Transforming growth factor-betal induce-s tumor stroma and reduces tumor infiltrate in cervical cancer显示文摘 | Hazelbag S Gorter A Kenter GG | 2002 | Hum Pathol2002，33，12： | 1 |
| 13 | Can initial serum cyfra 21-1,SCC antigen,and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis显示文摘 | Gaanenstroom KN Kenter GG Bonfrer JM | 2000 | Gynecol Oncol2000，77，1： | 1 |
| 14 | Induction of tumor-specific CD4 + and CD8 + T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine显示文摘 | Welters MJ Kenter GG Piersma SJ | 2008 | Clin Cancer Res2008，14，1： | 1 |
| 15 | Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage ⅠA to ⅡA显示文摘 | van den Tillaart SA Kenter GG Peters AA | 2009 | Int J Gynecol Cancer2009，19，1： | 1 |
| 16 | Induction of tumorspecific CD4^+ and CD8^+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine 显示文摘 | Welters MJ Kenter GG Piersma SJ | 2008 | Clin Cancer Res2008，14，1： | 1 |
| 17 | Association of antigen processing machinery and HLA class Ⅰ defects with clinicopathological outcome in cervical carcinoma Cancer显示文摘 | Mehta AM Jordanova ES Kenter GG | 2008 | Immunol Immunother2008，57，2： | 1 |
| 18 | Transforming growth factor-betal induces tumor stroma and reduces tumor infiltrate in cervical cancer显示文摘 | Hazelbag S Gorter A Kenter GG | 2002 | Hum Pathol2002，33，12： | 1 |
| 19 | Can initial serum cyfra 21-1,SCC antigen,and TPA levels in squamous cell cervical cancer predict lymph node metastasis or prognosis?显示文摘 | Gaarenstroom KN Kenter GG Bonfrer JM | 2000 | Gynecol Oncol2000，77，1： | 1 |
| 20 | Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer显示文摘 | Gaarenstroom KN BonfrerJM Kenter GG | 1995 | Cancer1995，76，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员